Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Sepiapterin bulk supplier for pharma manufacturers

Sepiapterin 1000 mg, 250 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets / oral powder

Available Strengths: 1000 mg, 250 mg

Reference Brands: Sephience (USA/EU)

Category: Orphan Drugs

Sepiapterin is a Orphan Drugs product available as Tablets / oral powder in strengths 1000 mg, 250 mg. It corresponds to the reference brand Sephience (USA/EU). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Ask About Access

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Sepiapterin? List it or send an offer →

Product Description:

Sepiapterin is a phenylalanine hydroxylase activator used for the treatment of hyperphenylalaninemia, including phenylketonuria (PKU). Marketed under the brand name Sephience, Sepiapterin supports metabolic control in patients who are unable to adequately process phenylalanine due to enzymatic deficiency. It works by enhancing the activity of phenylalanine hydroxylase, a key enzyme responsible for converting phenylalanine into tyrosine, thereby helping to reduce elevated blood phenylalanine levels.

Sepiapterin is a naturally occurring metabolite synthesized in the human body and serves as a biochemical precursor in the salvage pathway leading to the formation of tetrahydrobiopterin (BH4). BH4 is an essential cofactor required for the normal metabolism of phenylalanine and plays a critical role in the synthesis of neurotransmitter precursors derived from tyrosine and tryptophan, including dopamine and serotonin.

By restoring metabolic balance and improving enzymatic function, Sepiapterin provides a targeted therapeutic option for patients with disorders of phenylalanine metabolism. It is intended for long-term management and may be used alongside dietary control and other supportive treatments to achieve optimal metabolic outcomes.

How Sepiapterin is supplied today, and licensing ahead of patent expiry

Where sepiapterin is approved

Checked 3 Oct 2026
MarketStatusBrand · regulator · date
European Union Approved Sephience · European Commission · Jun 2025
United States Approved Sephience · FDA · Jul 2025
Generic / biosimilar None None approved as of the check date

Not approved in your country? A hospital or doctor can often still import it for a named patient, through a special-access, import-permit or compassionate-use route. We confirm which route applies in your country and the documents needed before quoting. Ask about named-patient supply →

Named-patient import Where a patient needs the product in a market where it is not registered, named-patient import is the lawful route. It requires the treating physician's documentation and authorisation from the destination regulator. We handle this pathway. Named-patient access
Authorised distribution For registered markets, supply runs through the manufacturer's authorised distribution channel. We can identify the authorised route for your market and tell you whether the product is registered there at all. Innovator sourcing
A genericised alternative Where the clinical requirement is the drug class rather than this specific molecule, there is often an off-patent alternative that is faster to register and materially cheaper. Tell us the indication and target market and we will say plainly whether one exists. Discuss alternatives
Licensing and generic development Patents expire country by country, and in many countries development and dossier filing can start before expiry under research and regulatory-review exemptions. We connect manufacturers developing this molecule, dossier holders, licensees and tech-transfer partners for markets where it is, or will become, off-patent. Partner on this molecule
Ask about Sepiapterin supply →
Back to Listing

Frequently Asked Questions

Sepiapterin is used for the treatment of phenylketonuria (PKU) to help lower and control elevated blood phenylalanine levels.

Sepiapterin is a synthetically manufactured compound that serves as a biochemical precursor to tetrahydrobiopterin (BH4).

The trade name of Sepiapterin is Sephience.

Sepiapterin (Sephience) is developed and manufactured by PTC Therapeutics.

The generic name of Sephience is Sepiapterin dihydrochloride.

The brand name of Sepiapterin is Sephience.

Sepiapterin is manufactured at PTC Therapeutics’ approved pharmaceutical manufacturing facilities, operating under international GMP and regulatory standards.

Sephience (Sepiapterin) is developed and sold by PTC Therapeutics. PharmaTradz handles enquiries for authorised supply of the originator product, named-patient import where it is not registered, and licensing or development work ahead of patent expiry.

Related Products

Pasireotide Diaspartate

Strength:
0.3 mg/mL, 0.6 mg/mL, 1.2 mg/mL, 10 mg, 20 mg, 30 mg

Form: Injection

Reference Brands: Signifor (USA/EU)

View Details
Palovarotene

Strength:
5 mg, 10 mg

Form: Capsules

Reference Brands: Sohonos (USA/EU)

View Details
Glycerol Phenylbutyrate

Strength:
1.1 g/mL

Form: Oral Solution

Reference Brands: Ravicti (USA)

View Details
Lumasiran Sodium

Strength:
94.5 mg/0.5 mL

Form: Injection

Reference Brands: Oxlumo (USA)

View Details
Vandetanib Tablets

Strength:
300 mg

Form: Tablets

Reference Brands: Caprelsa

View Details
Riluzole Tablets

Strength:
50 mg

Form: Tablets

Reference Brands: Rilutek(US)

View Details
Tetrabenazine Tablets

Strength:
25 mg, 50 mg, 75 mg

Form: Tablets

Reference Brands: Xenazine(US)

View Details
Nusinersen Intrathecal Injection

Strength:
12 mg/5ml

Form: Intrathecal Injection

Reference Brands: Spinraza(US)

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us